IDF21-0686 Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM. (April 2022) - Ritzel, R.; Ghosh, S.; Emral, R.; Malek, R.; Malik, R.; Zeng, L.; Huang, Y.; Mabunay, M.A.; Landgraf, W.; Guyot, P.; Schenk, E.; Pushkarna, D.